We are live on
!
Find out more
Rafferty Asset Management Portfolio holdings
AUM
$24.6B
1-Year Est. Return
47.06%
This Fund
S&P 500
This Quarter
Est. Return
+10.97%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$19B
AUM Growth
+$4.37B
(+30%)
Cap. Flow
+$3.05B
Cap. Flow
% of AUM
16.07%
Top 10 Holdings %
Top 10 Hldgs %
39.91%
Holding
1,362
New
110
Increased
730
Reduced
452
Closed
64
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$492M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$263M |
| 3 |
Qualcomm
QCOM
|
+$143M |
| 4 |
Broadcom
AVGO
|
+$118M |
| 5 |
iShares China Large-Cap ETF
FXI
|
+$105M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Gold Miners ETF
GDX
|
+$81.8M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$18.6M |
| 3 |
Chevron
CVX
|
+$11.9M |
| 4 |
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
|
+$10.9M |
| 5 |
ExxonMobil
XOM
|
+$8.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.28% |
| 2 | Financials | 15.39% |
| 3 | Healthcare | 5.04% |
| 4 | Energy | 4.05% |
| 5 | Consumer Discretionary | 2.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Green Plains
GPRE
$1.18B
| $6.62M | 0.03% |
190,389
+62,837
| +49% | +$2.34M |
|
|
AXON
277
Axon Enterprise
AXON
$42.5B
| $6.58M | 0.03% |
41,944
-3,893
| -8% | -$654K |
|
278
CDW
CDW
$18.9B
| $6.58M | 0.03% |
32,115
-14,916
| -32% | -$2.84M |
|
279
Ross Stores
ROST
$80.5B
| $6.52M | 0.03% |
57,086
+4,718
| +9% | +$528K |
|
280
Loews
L
$23.9B
| $6.51M | 0.03% |
112,801
+8,674
| +8% | +$492K |
|
|
PACW
281
DELISTED
PacWest Bancorp
PACW
| $6.48M | 0.03% |
143,451
+6,018
| +4% | +$280K |
|
|
STL
282
DELISTED
Sterling Bancorp
STL
| $6.45M | 0.03% |
250,104
-78,956
| -24% | -$2.04M |
|
|
CIVI
283
DELISTED
Civitas Resources
CIVI
| $6.44M | 0.03% |
131,563
+69,466
| +112% | +$3.69M |
|
|
TPTX
284
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $6.42M | 0.03% |
134,637
+91,821
| +214% | +$4.11M |
|
285
Incyte
INCY
$24.2B
| $6.38M | 0.03% |
86,943
-18,288
| -17% | -$1.23M |
|
286
iShares Global Clean Energy ETF
ICLN
$2.31B
| $6.37M | 0.03% |
301,031
+113,431
| +60% | +$2.61M |
|
287
Fate Therapeutics
FATE
$286M
| $6.28M | 0.03% |
107,268
+61,723
| +136% | +$3.5M |
|
288
Idexx Laboratories
IDXX
$44.1B
| $6.28M | 0.03% |
9,530
+452
| +5% | +$284K |
|
289
Equitable Holdings
EQH
$13B
| $6.27M | 0.03% |
191,269
+13,926
| +8% | +$457K |
|
290
BioCryst Pharmaceuticals
BCRX
$2.28B
| $6.27M | 0.03% |
452,637
+247,639
| +121% | +$3.28M |
|
291
Inovio Pharmaceuticals
INO
$55.7M
| $6.15M | 0.03% |
102,673
+40,285
| +65% | +$3.23M |
|
292
Halozyme
HALO
$9.79B
| $6.15M | 0.03% |
152,843
+77,287
| +102% | +$2.89M |
|
293
Clean Energy Fuels
CLNE
$427M
| $6.09M | 0.03% |
993,982
+129,366
| +15% | +$1.01M |
|
294
Ares Management
ARES
$28.9B
| $6.09M | 0.03% |
74,927
+8,897
| +13% | +$724K |
|
295
Kymera Therapeutics
KYMR
$8.51B
| $6.08M | 0.03% |
95,776
+49,027
| +105% | +$2.86M |
|
296
Enphase Energy
ENPH
$4.96B
| $6.07M | 0.03% |
33,198
+3,181
| +11% | +$664K |
|
297
Illumina
ILMN
$31B
| $6.07M | 0.03% |
16,405
+1,910
| +13% | +$724K |
|
|
FOLD
298
DELISTED
Amicus Therapeutics
FOLD
| $6.06M | 0.03% |
524,845
+220,295
| +72% | +$2.46M |
|
299
TG Therapeutics
TGTX
$7.96B
| $6.05M | 0.03% |
318,234
+213,638
| +204% | +$5.55M |
|
|
ISEE
300
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $6.04M | 0.03% |
361,429
+190,515
| +111% | +$3.12M |
|
Similar funds
CS
AF
SC
JG
Rafferty Asset Management's Q4 2021 Portfolio in Review
As of Q4 2021, Rafferty Asset Management held 1,362 positions worth $19B, up 30% from $14.6B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Rafferty Asset Management deployed $3.05B of net new capital in Q4 2021, opening 110 new positions and adding to 730 existing holdings. Its largest new stake was Aflac: 345,009 shares worth $20.1M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was VanEck Gold Miners ETF, an estimated $81.8M trimmed.
- Rafferty Asset Management's largest Q4 2021 buy was Aflac: 345,009 shares worth $20.1M.
- Rafferty Asset Management added most to iShares Core S&P 500 ETF in Q4 2021, an estimated $492M increase.
- Rafferty Asset Management's biggest Q4 2021 reduction was VanEck Gold Miners ETF, cutting an estimated $81.8M.
- Rafferty Asset Management fully exited CIMAREX ENERGY CO in Q4 2021, selling an estimated $8.07M.
- Rafferty Asset Management's ten largest holdings make up 40% of its $19B portfolio in Q4 2021.
- Rafferty Asset Management opened 110 new positions and closed 64 in Q4 2021.
- Rafferty Asset Management's portfolio value rose 30% quarter-over-quarter to $19B.
Based on Rafferty Asset Management's 13F filing for Q4 2021, filed 10 Feb 2022.